Utah sues manufacturers over 'unconscionable' insulin pricing

The Utah Attorney General's Office filed a lawsuit against insulin manufacturers on Thursday accusing them of what it calls an unconscionable insulin pricing scheme.

The Utah Attorney General's Office filed a lawsuit against insulin manufacturers on Thursday accusing them of what it calls an unconscionable insulin pricing scheme. (Jeffrey D. Allred, Deseret News )


Save Story
Leer en español

Estimated read time: 2-3 minutes

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

SALT LAKE CITY — About 8% of Utah adults have diabetes and a new lawsuit filed by the state calls the disease a "public health crisis."

The lawsuit filed on Thursday by Utah and the Utah Division of Consumer Protection claims multiple insulin companies are charging more than they should be, and taking money from Utahns.

It said the money that goes toward treating diabetes in Utah is $1.7 billion each year, one-fourth of the total money spent on health care in the state.

The Utah Attorney General's Office in the lawsuit claims there is an "insulin-pricing scheme" and calls it "unconscionable and deceptive."

The 112-page lawsuit names three manufacturers — Eli Lilly, Novo Nordisk and Sanofi, which manufacture most of the insulin and other diabetic medications available in the state, as defendants — along with CVS Caremark, Express Scripts and Optus RX, which serve as pharmacy benefit managers and administer prescription plans.

It asks the 3rd District Court to prohibit these companies from violating the Utah Consumer Sales Practices Act, and require them to pay damages to consumers and deal with civil penalties for previous law violations.

The lawsuit says insulins cost the manufacturers less than $2 per vial to produce, but the makers have increased the prices by "up to 1,000%" despite the cost of production going down over time.


Access to affordable insulin is, literally, a life-or-death issue.

– Utah Attorney General Sean Reyes


In a prepared statement about the lawsuit, Attorney General Sean Reyes said "unrestrained greed" can't impact health care, and these companies are making billions in profits through the markups.

"Access to affordable insulin is, literally, a life-or-death issue. ... This is one of the most egregious cases of avarice and inhumanity I have ever seen. It not only violates the law, but is morally repugnant too," Reyes said.

Margaret Woolley Busse, executive director of the Utah Department of Commerce, said the scheme is unlawful.

"We'll do everything in our power to hold these companies accountable for their unconscionable actions and for the damage they have caused to Utahns who rely on insulin for survival," she said.

The Utah Division of Consumer Protection is inviting diabetes patients in Utah to share their experiences online to participate in the lawsuit.

Related stories

Most recent Police & Courts stories

Related topics

UtahSalt Lake CountyHealthPolice & CourtsBusiness
Emily Ashcraft is a reporter for KSL.com. She covers issues in state courts, health and religion. In her spare time, Emily enjoys crafting, cycling and raising chickens.
KSL.com Beyond Series
KSL.com Beyond Business

KSL Weather Forecast

KSL Weather Forecast
Play button